CHIPing Away at Proteomics to Find Correlations with Myeloid Neoplasms.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38819216.
- Also identified by DOI 10.1158/1078-0432.CCR-24-0827 and PMC identifier 11309582.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Plasma proteomic profiling to identify associations with myeloid neoplasm (MN) risk highlights the potential of integrating proteins and genetic biomarkers for the detection of individuals at high risk of developing MN. These proteins also offer valuable insights into biological pathways and inflammatory mechanisms involved in the progression of clonal hematopoiesis to MN. See related article by Tran et al., p. 3220.
Medical subject headings
- Proteomics
- Biomarkers, Tumor